Literature DB >> 11762319

Human T lymphotropic virus type I (HTLV-1) associated myelopathy acquired through a liver transplant.

J J Zarranz, I Rouco, J C Gómez-Esteban, J Corral.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11762319      PMCID： PMC1737632          DOI： 10.1136/jnnp.71.6.818

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe?

Authors:  Michael R Marvin; Guy N Brock; Kwadwo Kwarteng; Ravi Nagubandi; Kadiyala V Ravindra; Mary Eng; Joseph F Buell
Journal:  Transplantation       Date:  2009-04-27       Impact factor: 4.939

2.  Post-transplantation HTLV-1 myelopathy in three recipients from a single donor.

Authors:  J J Zarranz Imirizaldu; J C Gomez Esteban; I Rouco Axpe; T Perez Concha; F Velasco Juanes; I Allue Susaeta; J M Corral Carranceja
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

3.  HTLV-1-associated myelopathy in a solid organ transplant recipient.

Authors:  Maria Jose Montesdeoca Andrade; Edgar Patricio Correa Diaz; Maria Eugenia Buestán
Journal:  BMJ Case Rep       Date:  2016-06-06

Review 4.  Donor-derived infection--the challenge for transplant safety.

Authors:  Jay A Fishman; Paolo A Grossi
Journal:  Nat Rev Nephrol       Date:  2014-09-02       Impact factor: 28.314
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.